Drug intelligence / Profile preview

omeprazole + sodium bicarbonate

Development stage
Approved
Lead developer
Salix Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Omeprazole + sodium bicarbonate is an oral pharmaceutical combination used to treat conditions associated with excessive stomach acid, such as gastroesophageal reflux disease (GERD), gastric and duodenal ulcers, erosive esophagitis, and for the prevention of upper gastrointestinal bleeding in critically ill patients. Omeprazole is a proton pump inhibitor (PPI) that works by irreversibly inhibiting the Gastric H+/K+ ATPase enzyme system on gastric parietal cells, thereby reducing gastric acid secretion. Sodium bicarbonate acts as an antacid by neutralizing existing stomach acid and also serves to protect omeprazole from degradation by stomach acid before absorption[1][2][3][4][5]. The combination allows for rapid onset of action compared to omeprazole alone[7].

Brand names
ZegeridZegerid OTCKonvomepOmePPi
Other names
omeprazole and sodium bicarbonate
02

Targets

ATP4A (Potassium–transporting ATPase alpha chain 1)

Beyond the preview

Go deeper on omeprazole + sodium bicarbonate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on omeprazole + sodium bicarbonate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call